Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

MoonLake Immunotherapeutics - Class A Ordinary Shares (NQ: MLTX )

46.76 +0.34 (+0.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MoonLake Immunotherapeutics - Class A Ordinary Shares

< Previous 1 2 3 4 5 Next >
MarketBeat Week in Review – 6/26 - 6/30
Markets headed into a holiday week cheering a lower-than-expected key inflation reading, but investors should expect volatility in a short trading week. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Stock Market Rally Roars Back Toward Highs; Carnival, Delta, Micron, Nvidia In Focus: Weekly Review
Major indexes rebounded strongly and many stocks flashed buy signals. 
Via Investor's Business Daily
Why MoonLake Immunotherapeutics Stock Skyrocketed This Week
Positive mid-stage results fueled a spike in the biotech's shares this week. 
Via The Motley Fool
MoonLake Immunotherapeutics Makes a Moonshot on Trials
Clinical-stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive clinical trial results. 
Via MarketBeat
Exposures Product Safety
Why Shares of MoonLake Immunotherapeutics Skyrocketed Monday
The company reported positive phase 2 clinical trial results. 
Via The Motley Fool
The Latest Analyst Ratings for MoonLake
Via Benzinga
MoonLake Immunotherapeutics Announces Pricing of $400 Million Upsized Public Offering of Class A Ordinary Shares
From MoonLake Immunotherapeutics AG
Via GlobeNewswire
Why MoonLake Immunotherapeutics Was Such a Healthy Stock Today
The heavily bullish sentiment on the company only grew on the second trading day of the week. 
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
MoonLake Immunotherapeutics, Applied Digital And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
BioMedNewsBreaks – MoonLake Immunotherapeutics’ (NASDAQ: MLTX) Shares See Significant Increase Based on Success of Phase 2 Trial
Via Investor Brand Network
Dow Surges Over 50 Points; Avalo Therapeutics Shares Plummet
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining more than 50 points on Monday. The Dow traded up 0.18% to 33,788.05 while the NASDAQ fell 0.61% to 13,410.63. The S&P 500,... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Crude Oil Rises; Carnival Shares Drop After Q2 Results
U.S. stocks traded lower midway through trading, with the Nasdaq dropping around 80 points on Monday. The Dow traded down 0.02% to 33,719.54 while the NASDAQ fell 0.53% to 13,420.67. The S&P 500, also... 
Via Benzinga
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular... 
Via Benzinga
MoonLake Immunotherapeutics (NASDAQ: MLTX) Announces Breakthrough Results for Sonelokimab in Phase 2 Trial
MoonLake Immunotherapeutics (NASDAQ: MLTX) has made significant strides with the successful outcome of their Phase 2 MIRA trial for sonelokimab, 
Via Spotlight Growth
Is the Stock Market Closed on the Fourth of July 2023?
Investors are looking for information about the stock market being closed on the Fourth of July and we've got the answers they seek! 
Via InvestorPlace
Is the Stock Market Closed on July 3, 2023?
Investors are preparing for Independence Day and that has some traders wondering if the stock market is closed on July 3, 2023. 
Via InvestorPlace
Insiders Promise Not to Sell AMTD Digital (HKD) Stock Until 2025
AMTD Digital (HKD) stock is on the move Monday after insiders promised not to sell shares on the public market for a few more years. 
Via InvestorPlace
Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Is FibroGen (FGEN) Stock Down 81% Today?
FibroGen (FGEN) stock is heading lower on Monday after the company's Phase 3 clinical trial failed to meet its primary endpoint. 
Via InvestorPlace
US Stocks Edge Higher; Goldman Sachs Downgrades Tesla To Neutral
U.S. stocks traded slightly higher this morning, with the Dow Jones gaining around 25 points on Monday. Following the market opening Monday, the Dow traded up 0.08% to 33,753.64 while the NASDAQ rose... 
Via Benzinga
Why Is MoonLake Immunotherapeutics (MLTX) Stock Up 93% Today?
MoonLake Immunotherapeutics (MLTX) stock is taking off on Monday after reporting positive results from a Phase 2 clinical trial. 
Via InvestorPlace
Why Mutual Fund Darling And Top 1% Stock MoonLake Immunotherapeutics Nearly Doubled
The company is treating a painful skin condition and could go up against AbbVie. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Lucid Stock Moved Into the Fast Lane, but This Nasdaq Biotech Was Monday's Big Winner
Markets looked poised to start the new week flat. 
Via The Motley Fool
Why MoonLake Immunotherapeutics Stock Is Shooting Higher Today
MoonLake Immunotherapeutics (NASDAQ: MLTX) released topline results from its Phase 2 MIRA trial evaluating the Nanobody sonelokimab in patients with moderate-to-severe 
Via Benzinga
MoonLake Immunotherapeutics achieves landmark milestone with positive Phase 2 results for Nanobody® sonelokimab in hidradenitis suppurativa
From MoonLake Immunotherapeutics AG
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2023
Via Benzinga
10 Short Squeeze Stocks To Watch: Getty Images, Intuitive Machines, Wearable Devices & More
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.